Hurley Capital LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 55 shares of the healthcare conglomerate’s stock, valued at approximately $28,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. NewSquare Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at about $30,000. Promus Capital LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $32,000. Pillar Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $40,000. Finally, DecisionPoint Financial LLC boosted its holdings in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares during the period. 87.86% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on UNH shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Barclays decreased their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $629.32.
Insider Buying and Selling
In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by insiders.
UnitedHealth Group Trading Down 2.9 %
NYSE UNH opened at $524.94 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a 50-day moving average of $509.24 and a 200-day moving average of $542.12. The firm has a market cap of $480.17 billion, a PE ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm earned $5.83 earnings per share. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- What Does Downgrade Mean in Investing?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- The Most Important Warren Buffett Stock for Investors: His Own
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Investing In Preferred Stock vs. Common Stock
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.